Morality
87
9
11
49
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.4%
3 terminated out of 87 trials
94.2%
+7.7% vs benchmark
6%
5 trials in Phase 3/4
4%
2 of 49 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 49 completed trials
Clinical Trials (87)
Mortality Outcome of Controlled Hypertension
Health Systems and Policy Contexts of Medical Oxygen
Time for a Diagnostic Paradigm Shift From STEMI/NSTEMI to OMI/NOMI
An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
Long-term Outcomes in Older Patients With Physical Restraint
Evaluation of a Multi-country Medical Oxygen Program
Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)
Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics
Polypharmacy and Outcomes After Elective Noncardiac Surgery
Changing the Surgical Team for Wound Closure and Surgical Site Infection
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels
We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours
PRISMA 7 and SARC-F in Predicting Emergency Department Readmission and Mortality
The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone vs. Quetiapine for the Treatment of ICU Delirium
Prognostic Effect of Body Composition in Cancer Survivors
Study of Hepatitis Eradication Receiving Protease Inhibitor Administration
Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight